Mar. 30, 2021

Suzhou Qurgen Pharmaceutical Co., Ltd. was established as the China headquarters, marking the launch of the company’s industrialization layout.

• On March 30, 2021, Suzhou Fuent Pharmaceutical Co., Ltd., invested by QURGEN, was officially registered and established with a registered capital of 10 million US dollars. 
• Since its establishment, the company has built the Qurgen Global Pharmaceutical Center and the China Oncology R&D Center. It undertakes the development of global protein process flows, the establishment of quality standards, the production of a series of protein products, as well as the production of various pharmaceuticals including oncology drugs, cardiac drugs, diabetes drugs, and antiviral drugs worldwide. 
• In addition, the company is responsible for the R&D, production, and sales of pancreatic cancer drugs and breast cancer drugs in the Greater China region.